Application
Immunofluorescence analysis of methanol-fixed HeLa, using alpha Tubulin antibody at 1:500 dilution.
Application
WB analysis of (1) HeLa, (2) Jurkat, (3) COS7, (4) NIH-3T3, (5) PC-12, (6) RAT2, (7) CHO, (8) MDBK and (9) MDCK lysates using alpha Tubulin antibody [B-5-1-2] at a concentration of 1 μg/ml.
Application
ICC/IF analysis of HEK293T cells transfected with a HA tagged protein using alpha Tubulin antibody [B-5-1-2] (green), HA antibody (red) and DAPI (blue).
WB
(C) Protein levels of VDAC1, T1M23 and COXIV in HEK293 cells were immunoblotted and quantified. After transfection of miR-34a-5p for 48 h, HEK293 cells were treated with CCCP for 24 h.
WB
F. QRT-PCR and WB analysis of genes which both were predicted to be targeted by miR-1205 in the KRAS signaling pathway.
WB
I. A549 or H460 cells were transfected with different dose of siKRAS (5, 10 nM) or NC for 72 h, p-ERK1/2, ERK1/2 and MDM4 protein levels were detected. J. A549 or H460 cells were treated with SCH772984 (0, 0.1, 1, 10 μM) for 24 h, and analyzed for the expression of p-ERK1/2 and MDM4.
WB
I. A549 or H460 cells were transfected with different dose of siKRAS (5, 10 nM) or NC for 72 h, KRAS signaling and E2F1 protein level were analyzed. J. A549 or H460 cells were treated with SCH772984 (0, 0.1, 1, 10 μM) for 24 h, and analyzed for the expression of p-ERK1/2 and E2F1.
WB
A. p-ERK1/2, ERK1/2, MDM4 and E2F1 protein levels were measured by western blot in A549 and H460 cells after transfected with indicated miRNA mimics or plasmids. B and C. MDM4 and E2F1 protein levels were detected after transfected with indicated miRNA mimics or plasmids
WB
D. KRAS signaling, MDM4 and E2F1 protein levels of NC group and miR-1205 group were detected and analyzed.